Privacy Regulatory Action definition

Privacy Regulatory Action means the institution of an investigation, an administrative hearing or civil charges by a Privacy Regulator under a Privacy Regulation arising out of an actual or alleged Privacy Breach.
Sample 1Sample 2Sample 3
Privacy Regulatory Action means a written request for information, civil investigative demand or civil proceeding brought by or on behalf of a governmental, regulatory authority, or authorized data protection authority.
Sample 1

Examples of Privacy Regulatory Action in a sentence

  • The Privacy Regulatory Action Policy explains the OAIC’s approach to using its privacy regulatory powers and communicating information publicly.

  • The Guide to Privacy Regulatory Action sets out a detailed explanation of particular privacy regulatory powers, looking at the legislative framework and purpose of the power, and the procedural steps the OAIC will take in the exercise of the regulatory power.

  • The procedure for applying for a declaration, and factors the Commissioner may consider, are outlined in the OAIC’s Guide to Privacy Regulatory Action — Chapter 9: Data Breach Incidents.

  • For more information about the Commissioner’s regulatory powers and how those powers are exercised, see the OAIC’s Privacy Regulatory Action Policy29 and the Guide to Privacy Regulatory Action.30Notifications of data breaches to the CommissionerHow to notify the CommissionerOnce an entity has reasonable grounds to believe there has been an eligible data breach and it is not exempted from notifying, it is required to provide notification to individuals at risk of serious harm and the Commissioner.

  • Claim Expense is included within and erodes the applicable Limits of Insurance.It is a condition precedent to coverage under the CLAIMS-MADE LIABILITY COVERAGES that the Claim, Privacy Regulatory Action or PCI-DSS Claim must be first made against an Insured during the Policy Period or any applicable Extended Reporting Period and reported to the Insurer in accordance with REPORTING OF CLAIMS AND EVENTS.

  • However, the Office of the Australian Information Commissioner (OAIC) will refer to this guide when undertaking its Privacy Act functions, including when investigating whether an entity has complied with its personal information security obligations (s 40) or when undertaking an assessment (s 33C).Information on when and how we might exercise our regulatory powers is available in the OAIC’s Privacy Regulatory Action Policy.

  • The Insurer shall pay on behalf of each Insured, Immediate Incident Response Expenses, Crisis Management Expenses, System Damage and Rectification Costs and Privacy Notification Expenses.Insuring Clause 2: Privacy Regulatory Actions The Insurer shall pay, on behalf of each Insured, Legal Liability Loss because of a Privacy Regulatory Action first made during the Policy Period.

  • The Commissioner's new approachAt the iappANZ Summit on 17 November 2014 Privacy Commissioner Timothy Pilgrim launched the Privacy Regulatory Action Policy.

  • Privacy Regulatory Fines means fines and penalties imposed by a governmental or regulatory body in aPrivacy Regulatory Action first made during the Policy Period which are: (a)non-criminal; and (b)insurable under the jurisdiction most favourable to insurability to which the Insurer and the Insuredincurring the fines or penalties or the Privacy Regulatory Action giving rise to them have a substantial relationship.

  • Releasing the documents at issue, will have the effect of circumventing the current s 40 investigations.Notably the OAIC’s Guide to Privacy Regulatory Action (the Guide) at paragraphs [1.31]-[1.33] creates an expectation that the OAIC will hold information pertaining to a privacy complaint in confidence.

Related to Privacy Regulatory Action

  • Regulatory Action means an administrative, regulatory, or judicial enforcement action, proceeding, investigation or inspection, FDA Form 483 notice of inspectional observation, warning letter, untitled letter, other notice of violation letter, recall, seizure, Section 305 notice or other similar written communication, injunction or consent decree, issued by the FDA or a federal or state court.

  • Privacy Regulations means the Privacy and Electronic Communications (EC Directive) Regulations 2003 as amended in 2004, 2011, 2015 and 2016 and as may be further amended from time to time;

  • regulatory action level RBC means the product of 1.5 and its authorized control level RBC;

  • HIPAA means the Health Insurance Portability and Accountability Act of 1996, as amended.

  • Retaliatory action means action which includes, but is not limited to, the refusal to continue an agreement, or a material reduction in the quality of service or quantity of products available to a wholesaler under an agreement, which refusal or reduction is not made in good faith.

  • Regulatory Data means any and all research data, pharmacology data, chemistry, manufacturing, and control data, preclinical data, clinical data or all other documentation submitted, or required to be submitted, to Regulatory Authorities in association with regulatory filings for the Product in the Field (including any Drug Master Files (DMFs), Chemistry, Manufacturing and Control (“CMC”) data, or similar documentation).

  • Biological safety cabinet means a containment unit suitable for the preparation of low to moderate risk agents where there is a need for protection of the product, personnel, and environment, according to National Sanitation Foundation (NSF) Standard 49.

  • Corrective Action Plan has the meaning set forth in Section II.A.2.

  • Contractor Sensitive Information means any information provided by the Contractor to the Authority (disregarding any protective marking or assertion of confidentiality) which: is specified as Contractor Sensitive Information in Schedule 7 and has not lost its sensitivity according to the justifications and durations set out in that Schedule; and is exempt information pursuant to sections 33(1) or 36, 38 or 39 of FOISA (having regard for that purpose to the public interest there might be in disclosing such information as referred to in section 2(1)(b) of FOISA).

  • Adverse drug reaction means any undesirable or unexpected medication related event that requires discontinuing a medication or modifying the dose, requires or prolongs hospitalization, results in disability, requires supportive treatment, is life-threatening or results in death, results in congenital anomalies, or occurs following vaccination.

  • Indigenous Peoples Safeguards means the principles and requirements set forth in Chapter V, Appendix 3, and Appendix 4 (as applicable) of the SPS;

  • health and safety file means a file, or other record containing the information in writing required by these Regulations "health and safety plan" means a site, activity or project specific documented plan in accordance with the client's health and safety specification;

  • Contractor Commercially Sensitive Information means the information listed in the Contractor Commercial Sensitive Information Annex to the Contract being information notified by the Contractor to the Authority which is acknowledged by the Authority as being commercially sensitive information.

  • health and safety specification means a site, activity or project specific document prepared by the client pertaining to all health and safety requirements related to construction work;

  • Detailed manufacturing or process data means technical data that describe the steps, sequences, and conditions of manufacturing, processing or assembly used by the manufacturer to produce an item or component or to perform a process.

  • HIPAA Regulations means the regulations promulgated under HIPAA by the United States Department of Health and Human Services, including, but not limited to, 45 C.F.R. Part 160 and 45 C.F.R. Part 164.

  • Investigational Product means the Study Drug identified above and the control material, as further detailed in the Protocol;

  • Regulatory asset means an asset recorded on the books of an

  • DMF means any drug master file filed with the FDA, and any equivalent filing in other countries or regulatory jurisdictions.

  • The HIPAA Privacy Rule means the Standards for Privacy of Individually 10 Identifiable Health Information at 45 CFR Part 160 and Part 164, Subparts A and E.

  • Corrective action means action taken to eliminate the cause of a potential or real non- conformity or other undesirable situation;

  • Post-consumer recovered material means any product used by a consumer, including a business that purchases the material, that has served its intended end use, and that has been separated or diverted from the solid waste stream for the purpose of use, reuse, or recycling.

  • Emergency Action Plan means the plan referred to in Section I.G of Schedule 2 to this Agreement, detailing the activities, budget, implementation plan, and monitoring and evaluation arrangements, to respond to the Eligible Crisis or Emergency.

  • HIPAA Privacy Rule as defined in 45 CFR Part 164, Subparts A and E.

  • Legislative action means the development, drafting, introduction, consideration, modification, adoption, rejection, review, enactment or defeat of any bill, resolution, amendment, report, nomination, proposed administrative rule or other matter by the legislature or by either house or any committee, subcom- mittee, joint or select committee thereof, or by a legislator or employee of the legislature acting in an official capacity. “Legis- lative action” also means the action of the governor in approving or vetoing any bill or portion thereof, and the action of the gover- nor or any agency in the development of a proposal for introduc- tion in the legislature.

  • Drug Master File or “DMF” is described in 21 C.F.R. Part 314.420. A DMF is a submission to the FDA that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs.